Alzheimer Disease Drug (Alzheimer Disease) Equipment
-
Manufactured by BioArctic ABbased in SWEDEN
At BioArctic, research is in progress to develop new antibodies for the treatment of Alzheimer’s disease aimed at slowing down or stopping disease progression by addressing novel ...
-
Manufactured by BioArctic ABbased in SWEDEN
AD1503 is an innovative project to develop a disease modifying treatment for prodromal and mild Alzheimer’s disease. ...
-
Manufactured by BioArctic ABbased in SWEDEN
AD1502 is an innovative project to develop a disease modifying treatment for prodromal and mild Alzheimer’s disease. ...
-
Manufactured by BioArctic ABbased in SWEDEN
AD1801 is an innovative project to develop disease modifying treatment of Alzheimer’s disease, targeting Apolipoprotein E (ApoE), a different molecule than those targeted in the projects BAN2401 and BAN2401 ...
-
Manufactured by BioArctic ABbased in SWEDEN
In Alzheimer’s disease soluble, toxic amyloid beta aggregates are believed to contribute to the neurodegenerative process. Lecanemab, a anti amyloid-beta protofibril antibody, selectively binds to these forms of amyloid beta and eliminates them. The antibody’s unique profile is highly selective for amyloid beta ...
-
Manufactured by NeuroScientific Biopharmaceuticals Ltd.based in AUSTRALIA
Multiple indications with unmet medical need. “Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt neurodegeneration. We believe that EmtinB has potential to bridge this gap and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you